Bank of New York Mellon
NTUS

Bank of New York Mellon’s Natus Medical Inc NTUS Stock Holding History

Bank of New York Mellon’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-313,577
Closed -$10.3M – 4650
2022
Q2 		$10.3M Sell
313,577
-19,204
-6% -$607K ﹤0.01% 1922
2022
Q1 		$8.74M Sell
332,781
-1,388
-0.4% -$33.9K ﹤0.01% 2144
2021
Q4 		$7.93M Buy
334,169
+13,222
+4% +$326K ﹤0.01% 2230
2021
Q3 		$8.05M Buy
320,947
+6,281
+2% +$160K ﹤0.01% 2239
2021
Q2 		$8.18M Sell
314,666
-39,015
-11% -$1.06M ﹤0.01% 2249
2021
Q1 		$9.06M Sell
353,681
-519
-0.1% -$13.3K ﹤0.01% 2142
2020
Q4 		$7.1M Sell
354,200
-158,119
-31% -$3.1M ﹤0.01% 2183
2020
Q3 		$8.78M Sell
512,319
-248,036
-33% -$4.69M ﹤0.01% 1919
2020
Q2 		$16.6M Buy
760,355
+4,988
+0.7% +$114K ﹤0.01% 1557
2020
Q1 		$17.5M Buy
755,367
+62,694
+9% +$1.82M 0.01% 1378
2019
Q4 		$22.9M Buy
692,673
+305,143
+79% +$9.78M 0.01% 1488
2019
Q3 		$12.3M Buy
387,530
+5,805
+2% +$169K ﹤0.01% 1813
2019
Q2 		$9.81M Sell
381,725
-3,679
-1% -$93.7K ﹤0.01% 1975
2019
Q1 		$9.78M Sell
385,404
-1,385
-0.4% -$41.3K ﹤0.01% 1989
2018
Q4 		$13.2M Buy
386,789
+1,762
+0.5% +$57.3K ﹤0.01% 1761
2018
Q3 		$13.7M Sell
385,027
-22,672
-6% -$800K ﹤0.01% 1848
2018
Q2 		$14.1M Sell
407,699
-4,079
-1% -$143K ﹤0.01% 1835
2018
Q1 		$13.9M Sell
411,778
-53,913
-12% -$1.71M ﹤0.01% 1815
2017
Q4 		$17.8M Sell
465,691
-54,432
-10% -$2.17M ﹤0.01% 1642
2017
Q3 		$19.5M Sell
520,123
-453,223
-47% -$16M 0.01% 1567
2017
Q2 		$36.3M Buy
973,346
+86,192
+10% +$3.11M 0.01% 1173
2017
Q1 		$34.8M Sell
887,154
-21,433
-2% -$804K 0.01% 1207
2016
Q4 		$31.6M Sell
908,587
-35,318
-4% -$1.39M 0.01% 1238
2016
Q3 		$37.1M Sell
943,905
-57,579
-6% -$2.3M 0.01% 1061
2016
Q2 		$37.9M Buy
1,001,484
+87,938
+10% +$2.95M 0.01% 1019
2016
Q1 		$35.1M Buy
913,546
+316,719
+53% +$11.8M 0.01% 1050
2015
Q4 		$28.7M Sell
596,827
-138,885
-19% -$6.43M 0.01% 1156
2015
Q3 		$29M Sell
735,712
-124,052
-14% -$5.27M 0.01% 1171
2015
Q2 		$36.6M Sell
859,764
-77,398
-8% -$3.08M 0.01% 1086
2015
Q1 		$37M Buy
937,162
+72,073
+8% +$2.66M 0.01% 1074
2014
Q4 		$31.2M Sell
865,089
-180,241
-17% -$6.05M 0.01% 1155
2014
Q3 		$30.8M Sell
1,045,330
-181,445
-15% -$5.01M 0.01% 1153
2014
Q2 		$30.8M Sell
1,226,775
-28,298
-2% -$700K 0.01% 1196
2014
Q1 		$32.4M Sell
1,255,073
-12,130
-1% -$306K 0.01% 1158
2013
Q4 		$28.5M Buy
1,267,203
+21,057
+2% +$407K 0.01% 1239
2013
Q3 		$17.7M Sell
1,246,146
-526,475
-30% -$7.04M 0.01% 1480
2013
Q2 		$24.2M Buy
+1,772,621
New +$24.2M 0.01% 1240

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of New York Mellon's NTUS Position: Q3 2022 in Review

Bank of New York Mellon sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 313,577 shares — an estimated $10.3M sold.

Bank of New York Mellon first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $37.9M in Q2 2016. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Bank of New York Mellon reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 313,577 Natus Medical Inc shares in Q3 2022, an estimated $10.3M.
  • Bank of New York Mellon first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
  • Bank of New York Mellon's Natus Medical Inc position peaked at $37.9M in Q2 2016.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Bank of New York Mellon's 13F filing for Q3 2022, filed 14 Nov 2022.